HHS may reconsider blocked 340B rebate pilot after courts halt the program, signaling potential changes for drug discount policies in 2024.

On January 7, 2026, the First Circuit Court of Appeals denied the federal government’s emergency motion to stay a district ...

The National Organ Transplant Act (1984) established the OPTN to coordinate organ allocation and transplantation in the U.S.

The Health Resources and Services Administration yesterday announced updated cervical cancer screening guidelines, including optional self-collection of samples for screening. The guidelines also ...

The federal 340B program has become a thorn in the side of pharmaceutical companies, who point to the drug discount program’s sprawling growth amid what they contend is lack of oversight. After ...

For the first time, many people in the United States who should be screened for cervical cancer will have an alternative to ...

Under the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), the Health Resources and Services Administration (HRSA) of the Department of Health and Human Services (HHS) is authorized to ...

A major update to federal women’s health preventive guidance will make it easier for women to get screened for cervical ...

This past September, a sub-agency of the Department of Health and Human Services (HHS) threatened to kick a pharmaceutical company out of Medicare because the company, in line with federal law, ...

HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its toes into the 340B debate, hospital groups express concerns about the potential for cash flow ...

The Dobbs v. Jackson Women’s Health Organization decision reversing the constitutional right to abortion has thrust contraceptive access into the spotlight. Dobbs has spurred new concerns over the ...